| Overview |
| bs-2997R-PerCP-Cy5.5 |
| JNK3 Polyclonal Antibody, PerCP-Cy5.5 Conjugated |
| IF(IHC-P), IF(IHC-F), IF(ICC) |
| Mouse, Rat |
| Human, Dog, Cow, Pig, Chicken, Rabbit |
| Specifications |
| PerCP-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human JNK3/MAPK10 |
| 251-360/384 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5602 |
| Cytoplasm, Nucleus, Cell membrane |
| cJun N terminal kinase 3; MAP kinase p49 3F12; Stress activated protein kinase JNK3; c Jun kinase 3; JNK3; JNK3A; MAP kinase; mitogen activated protein kinase 10; p493F12; p54bSAPK; PRKM10; protein kinase mitogen activated 10 ; stress activated protein kinase beta. |
| MAPK10 (JNK3) is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This protein is a neuron-specific form of c-Jun N-terminal kinases (JNKs). Through its phosphorylation and nuclear localization, this kinase plays regulatory roles in the signaling pathways of neuronal apoptosis. Beta-arrestin 2, a receptor-regulated MAP kinase scaffold protein, is found to interact with and stimulate the phosphorylation of this kinase by MAP kinase kinase 4 (MKK4). Cyclin-dependent kianse 5 (CDK5) can phosphorylate and inhibit the activity of this kinase, which may be important in preventing neuronal apoptosis. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz